Akademik Veri Yönetim Sistemi
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, cilt.29, sa.3, ss.112-119, 2014 (ESCI, Scopus)
The prevalence of sleep disruptions have been reported in 30-50% of cancer patients. Most insomnia cases that involve cancer patients occur in various stages of the disease, with a particular emphasis in the advanced stages. In the literature, insomnia is a specific sleep disruption that is more defined in cancer patients as a symptom or clinical disorder. In oncology patients, insomnia is not only one symptom but a cluster of symptoms that are associated with many risk factors. Better evaluation of the risk factors in cancer patients will be of great assistance for the treatment of sleep disorders in cancer patients. Since there are various diagnostic tests for insomnia, it is important that the diagnosis and follow up is in parallel with these methods. The methods should be proven reliable to validate diagnosis and outcomes for oncology patients.